Stoke Therapeutics

#药闻简讯# $Stoke Therapeutics(STOK)$
2027 年中 Ph3 EMPEROR研究数据
2027 年上半年将开始滚动保密协议
关于加快 zorevunersen 的开发、注册和交付给患者的潜在机会，讨论仍在继续

#药闻简讯# 2025年11月17日 ——$Biogen制药(BIIB)$ 与致力于通过RNA药物激发人体潜能来恢复蛋白质表达的生物技术公司斯托克治疗公司$Stoke Therapeutics(STOK)$ 今日联合宣布，针对Dravet综合征患者开展的为期两年的前瞻性自然史研究BUTTERFLY的最终数据已正式发表。Dravet综合征是一种严重的发育...

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001522780-25-000008  Size: 14 KB 网页链接

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001966716-25-000006  Size: 14 KB 网页链接

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001780088-25-000006  Size: 14 KB 网页链接

$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009868  Act: 33  Size: 7 KB 网页链接

$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-008873  Act: 33  Size: 4 KB 网页链接

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001522780-25-000010  Size: 8 KB 网页链接

$Stoke Therapeutics(STOK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001771015-25-000011  Act: 34  Size: 6 KB 网页链接

$Stoke Therapeutics(STOK)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000947263-25-000009  Act: 34  Size: 7 KB 网页链接

$Stoke Therapeutics(STOK)$ 多伦多道明银行提交了13G表格，显示其增持了Stoke Therapeutics公司股份。该银行现持有3,173,258股，占公司5.8%的股权。此次申报显示持仓总价值大幅增长至84,123,069.58美元，较此前价值增长133.57%。相关股份从关联机构Cowen Financial Products LLC转移至多伦多道明...

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001780081-25-000004  Size: 7 KB 网页链接

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001780081-25-000006  Size: 5 KB 网页链接

$Stoke Therapeutics(STOK)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-308781  Act: 34  Size: 205 KB 网页链接

$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009875  Act: 33  Size: 7 KB 网页链接

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001966716-25-000008  Size: 16 KB 网页链接

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001522780-25-000009  Size: 16 KB 网页链接

$Stoke Therapeutics(STOK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-26-000519  Act: 34  Size: 11 KB 网页链接

$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001780088-25-000005  Size: 14 KB 网页链接

$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009951  Act: 33  Size: 8 KB 网页链接